Attribution standard
Every finding on an Argus HQ record page is attributed to the FDA document it came from. We reproduce the source record — a Warning Letter, a recall notice, an approval record, a Form 483 observation — in full, and any analysis we add sits alongside it, clearly separated, and never replaces it. If a claim on our site can’t be traced back to a specific FDA record, it shouldn’t be on our site. Readers should never have to take our word for something FDA has already said publicly; the source document is always one click away.
No-speculation rule
We describe what FDA has stated in the record. We do not speculate about a company’s future regulatory outcomes, financial condition, guilt, or intent, and we do not offer legal, financial, or medical advice. This applies equally to human-written and AI-drafted content on this site — see the Methodology page for how our AI enrichment is scoped and fact-checked against the source record before it publishes.
Corrections process and SLA
Anyone can report an error to corrections@argushq.ai: a misread field, a misattributed company, a broken source link, a summary that doesn’t match its source document. Our process:
- You email us the page URL and what’s wrong.
- We review the report against the original FDA source document.
- Confirmed errors are fixed on the live page within 2 business days.
- We add a dated correction note directly on the affected page so the correction history is visible, not silently overwritten.
Separation of database content from marketing content
Argus HQ publishes two kinds of content: database pages (Warning Letters, recalls, approvals, 483s, company profiles) and marketing/product pages (pricing, the homepage, blog posts about the product itself). Database pages are never edited, delayed, or omitted to serve a sales or marketing objective. Our subscription business is described plainly on the About page; it does not influence which public records we publish or how we describe them.